Skip to main content

Logo 659 (Ropinirole Hydrochloride Extended-Release 4 mg)

Pill with imprint Logo 659 is Blue, Elliptical/Oval and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Elizabeth LLC.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 659

Ropinirole Hydrochloride Extended-Release

Logo 659
4 mg
16.00 mm
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Elizabeth LLC
Inactive Ingredients
silicon dioxide, croscarmellose sodium, castor oil, hypromelloses, lactose monohydrate, magnesium stearate, maltodextrin, titanium dioxide, ferrosoferric oxide, FD&C Yellow No. 6, FD&C Blue No. 2, polydextrose, polyethylene glycol, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00228-3659 Actavis Pharma, Inc.
42291-0714 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.